Elucidating MDLC’s molecular features
The study’s results indicate that spatial sequencing of mixed-type breast cancers could inform personalised treatment.
List view / Grid view
The study’s results indicate that spatial sequencing of mixed-type breast cancers could inform personalised treatment.
Researchers have developed a new tool called ‘Uveal Melanoma Immunogenic Score’ to predict which patients will respond to adoptive therapy.
Tumours with a greater IGR burden could respond better to immune checkpoint blockades, advancing precise treatments for patients.
The new antibodies can neutralise certain H1 and H3 strains with or without the 133a insertion, which could lead to improved vaccines.
Novel findings about the tafazzin gene offers a potential new target and drug candidate for Barth syndrome.
In this article, Drug Target Review's Izzy Wood uncovers the cutting-edge breakthroughs in T cell research that are revolutionising our understanding of the immune system and paving the way for new therapies and treatments.
US researchers use genome sequencing to reveal genetic basis for disabling pansclerotic morphea, a severe inflammatory disease.
US researchers usings a ‘SNAP’ receptor system can customise immunotherapies for targeted treatments of cancer and other diseases.
US researchers have connected a rare T cell called Th9 with treating allergies, testing in mouse models with asthma.
Researchers from the University of Pittsburgh have found that age-associated B cells (ABCs) are key drivers of lupus, a chronic autoimmune disorder that attacks the patient's own organs.
This article outlines three innovative studies that use nanotechnology to deliver a new immunotherapy approach towards cancers.
University of Pittsburgh researchers have designed cancer-fighting nanoparticles that co-deliver a chemotherapy drug and a novel immunotherapy
A new study from the University of Pittsburgh and Carnegie Mellon University may solve the puzzle of how cells control their volume.
Scientists at the University of Pittsburgh have been using computational modelling to understand the body’s immune responses to avian flu.
Scientists have identified potential cancer drugs to treat pulmonary hypertension using experimental and computational approaches.